Labeler
BluePoint Laboratories NDC Codes
BluePoint Laboratories lists 349 finished drug products in the FDA NDC Directory under NDC labeler code 68001.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Enoxaparin Sodium, Nadolol, Dasatinib, doxorubicin hydrochloride, Metoprolol Succinate, Aprepitant, Zenatane, Decitabine, Labetalol Hydrochloride, Cyclophosphamide, Fluoxetine, Etoposide, Haloperidol decanoate, leucovorin calcium, Mitomycin
- Active ingredients
- Enoxaparin sodium, Nicotine, Nadolol, Dasatinib, Doxorubicin hydrochloride, Metoprolol succinate, Isotretinoin, Decitabine, Labetalol hydrochloride, Cyclophosphamide, Aprepitant, Fluoxetine hydrochloride
- NDC labeler codes
- 68001
- Strengths (from the 100 most recently listed products)
- Doxorubicin hydrochloride 2 mg/mL; Enoxaparin sodium 100 mg/mL; Etoposide 20 mg/mL; Decitabine 50 mg/10mL; Nicotine 7 mg/24h; Nicotine 14 mg/24h; Nicotine 21 mg/24h; Nadolol 20 mg/1; Nadolol 40 mg/1; Nadolol 80 mg/1; Enoxaparin sodium 150 mg/mL; Fluorouracil 50 mg/mL; Cisplatin 1 mg/mL; Palonosetron hydrochloride .25 mg/5mL; Labetalol hydrochloride 300 mg/1; Paclitaxel 6 mg/mL; Teriparatide 250 ug/mL; Cyclophosphamide 500 mg/25mL; Cyclophosphamide 1 g/50mL; Cyclophosphamide 2 g/100mL
- Dosage forms
- Injection, Tablet, Tablet, Film coated, Injection, Powder, Lyophilized, For solution, Patch, Extended release, Capsule, Injection, Solution, Tablet, Extended release, Capsule, Gelatin coated, Injection, Solution, Concentrate, Injection, Suspension, Liposomal, Injection, Powder, For solution, Injectable, Liposomal, Solution, Tablet, Film coated, Extended release, Kit, Patch, Injection, Powder, Lyophilized, For suspension, Gel, Spray, Capsule, Extended release
- Routes
- Oral, Intravenous, Subcutaneous, Intramuscular, Transdermal, Topical, Ophthalmic, Nasal
- Drug classes (FDA established)
- beta-Adrenergic Blocker, Nucleoside Metabolic Inhibitor, Kinase Inhibitor, Low Molecular Weight Heparin, Cholinergic Nicotinic Agonist, Anthracycline Topoisomerase Inhibitor, Serotonin Reuptake Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Retinoid, Microtubule Inhibitor, Topoisomerase Inhibitor, Typical Antipsychotic, Folate Analog, Alkylating Drug, Anti-epileptic Agent, Mood Stabilizer, Nonsteroidal Anti-inflammatory Drug, Aminoketone, Bisphosphonate, Platinum-based Drug, Serotonin-3 Receptor Antagonist, Parathyroid Hormone Analog, Histamine-1 Receptor Antagonist, Histamine-1 Receptor Inhibitor, Mast Cell Stabilizer, Cytochrome P450 17A1 Inhibitor, Amide Local Anesthetic, Antiarrhythmic, Corticosteroid, Opioid Antagonist, Vitamin B12, Estrogen Receptor Antagonist, Osmotic Laxative, Potassium Salt
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 131 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Cyclophosphamide | Cyclophosphamide 500 mg/25mL | Injection, Powder, For solutionIntravenous, Oral | 68001-442 | 68001-0442-26 | — |
| Cyclophosphamide | Cyclophosphamide 1 g/50mL | Injection, Powder, For solutionIntravenous, Oral | 68001-443 | 68001-0443-27 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-457 | 68001-0457-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-458 | 68001-0458-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-459 | 68001-0459-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-460 | 68001-0460-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 100 mg/mL | InjectionSubcutaneous | 68001-461 | 68001-0461-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | 68001-462 | 68001-0462-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 150 mg/mL | InjectionSubcutaneous | 68001-463 | 68001-0463-42 | — |
| Enoxaparin Sodium | Enoxaparin sodium 300 mg/3mL | InjectionIntravenous, Subcutaneous | 68001-464 | 68001-0464-41 | — |
| Cyclophosphamide | Cyclophosphamide 2 g/100mL | Injection, Powder, For solutionIntravenous, Oral | 68001-444 | 68001-0444-32 | — |
| Ziprasidone Hydrochloride | Ziprasidone hydrochloride 40 mg/1 | CapsuleOral | 68001-451 | 68001-0451-06 | — |
| Ziprasidone Hydrochloride | Ziprasidone hydrochloride 60 mg/1 | CapsuleOral | 68001-452 | 68001-0452-06 | — |
| Ziprasidone Hydrochloride | Ziprasidone hydrochloride 80 mg/1 | CapsuleOral | 68001-453 | 68001-0453-06 | — |
| Ziprasidone Hydrochloride | Ziprasidone hydrochloride 20 mg/1 | CapsuleOral | 68001-450 | 68001-0450-06 | — |
| Loratadine | Loratadine 10 mg/1 | TabletOral | 68001-438 | 68001-0438-0068001-0438-0468001-0438-96+1 more | — |
| Loratadineloratadine oral | Loratadine 5 mg/5mL | SolutionOral | 68001-449 | 68001-0449-98 | — |
| Trospium Chloride | Trospium chloride 60 mg/1 | Capsule, Extended releaseOral | 68001-427 | 68001-0427-04 | — |
| Zoledronic acid | Zoledronic acid 4 mg/5mL | InjectionIntravenous | 68001-437 | 68001-0437-25 | — |
| Fexofenadine hydrochloride | Fexofenadine hydrochloride 180 mg/1 | TabletOral | 68001-440 | 68001-0440-0068001-0440-04 | — |
| Omeprazole | Omeprazole 20 mg/1 | Tablet, Delayed releaseOral | 68001-441 | 68001-0441-3968001-0441-4068001-0441-98 | — |
| Cetirizine Hydrochloride (Allergy)cetirizine hydrochloride | Cetirizine hydrochloride 10 mg/1 | TabletOral | 68001-436 | 68001-0436-0468001-0436-9668001-0436-97 | — |
| Fexofenadine hydrochloride | Fexofenadine hydrochloride 60 mg/1 | TabletOral | 68001-439 | 68001-0439-00 | — |
| Ramipril | Ramipril 1.25 mg/1 | CapsuleOral | 68001-428 | 68001-0428-00 | — |
| Ramipril | Ramipril 2.5 mg/1 | CapsuleOral | 68001-429 | 68001-0429-00 | — |
| Ramipril | Ramipril 5 mg/1 | CapsuleOral | 68001-430 | 68001-0430-0068001-0430-03 | — |
| Ramipril | Ramipril 10 mg/1 | CapsuleOral | 68001-431 | 68001-0431-0068001-0431-03 | — |
| Fosaprepitant | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-421 | — | — |
| Gabapentin | Gabapentin 600 mg/1 | TabletOral | 68001-411 | 68001-0411-0068001-0411-03 | — |
| Gabapentin | Gabapentin 800 mg/1 | TabletOral | 68001-412 | 68001-0412-0068001-0412-03 | — |
| Leucovorin Calcium | Leucovorin calcium 100 mg/10mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 68001-416 | 68001-0416-36 | — |
| Leucovorin Calcium | Leucovorin calcium 200 mg/20mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 68001-417 | 68001-0417-37 | — |
| Leucovorin Calcium | Leucovorin calcium 350 mg/17.5mL | Injection, Powder, Lyophilized, For solutionIntramuscular, Intravenous | 68001-418 | 68001-0418-38 | — |
| Ertapenemertapenem sodium | Ertapenem sodium 1 g/20mL | InjectionIntramuscular, Intravenous | 68001-408 | 68001-0408-31 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 5 g/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-406 | 68001-0406-73 | — |
| Vancomycin Hydrochloride | Vancomycin hydrochloride 10 g/1 | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-407 | 68001-0407-75 | — |
| Abirateroneabiraterone acetate | Abiraterone acetate 250 mg/1 | TabletOral | 68001-489 | 68001-0489-07 | — |
| Potassium Chloride | Potassium chloride 750 mg/1 | Capsule, Extended releaseOral | 68001-396 | 68001-0396-0068001-0396-03 | — |
| Famotidine | Famotidine 20 mg/1 | Tablet, Film coatedOral | 68001-397 | 68001-0397-0068001-0397-08 | — |
| Famotidine | Famotidine 40 mg/1 | Tablet, Film coatedOral | 68001-398 | 68001-0398-0068001-0398-03 | — |
| Fluoxetinefluoxetine hydrochloride | Fluoxetine hydrochloride 10 mg/1 | CapsuleOral | 68001-399 | 68001-0399-0068001-0399-08 | — |
| Fluoxetinefluoxetine hydrochloride | Fluoxetine hydrochloride 20 mg/1 | CapsuleOral | 68001-400 | 68001-0400-0068001-0400-08 | — |
| Fluoxetinefluoxetine hydrochloride | Fluoxetine hydrochloride 40 mg/1 | CapsuleOral | 68001-401 | 68001-0401-0068001-0401-0368001-0401-04 | — |
| Levetiracetam | Levetiracetam 250 mg/1 | Tablet, Film coatedOral | 68001-402 | 68001-0402-0368001-0402-07 | — |
| Levetiracetam | Levetiracetam 500 mg/1 | Tablet, Film coatedOral | 68001-403 | 68001-0403-0368001-0403-07 | — |
| Levetiracetam | Levetiracetam 750 mg/1 | Tablet, Film coatedOral | 68001-404 | 68001-0404-0368001-0404-07 | — |
| Levetiracetam | Levetiracetam 1000 mg/1 | Tablet, Film coatedOral | 68001-405 | 68001-0405-06 | — |
| Triamterene and Hydrochlorothiazide | Triamterene 37.5 mg/1; Hydrochlorothiazide 25 mg/1 | TabletOral | 68001-387 | 68001-0387-03 | — |
| Triamterene and Hydrochlorothiazide | Triamterene 75 mg/1; Hydrochlorothiazide 50 mg/1 | TabletOral | 68001-388 | 68001-0388-0068001-0388-03 | — |
| Mitomycin | Mitomycin 5 mg/10mL | Injection, Powder, Lyophilized, For solutionIntravenous | 68001-389 | 68001-0389-36 | — |
BluePoint Laboratories: common questions
- What is BluePoint Laboratories's NDC labeler code?
- 68001. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for BluePoint Laboratories?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.